Prior to this, Maotai had reached a cooperative relationship with Revision Pharmaceutical, which also had the same intention to enter the health wine market. 2065438+April 2007, the strategic cooperation framework agreement was amended and signed with Kweichow Moutai. Both parties indicated that they would cooperate in the research, development, production and sales of health wine to build a brand of health wine with market competitiveness. However, the health wine market is still in the growth stage, and the market scale is not large.
Contrary to the bleak health wine industry, the sub-industry of Maotai-flavor wine is very hot, which can be seen from the revenue of listed company Kweichow Moutai. In 2020, Kweichow Moutai achieved a total revenue of 94.993 billion yuan, a year-on-year increase of 65.438+00.29%, and the net profit attributable to owners of the parent company reached 46.697 billion yuan, a year-on-year increase of 65.438+03.33%.
Some insiders believe that thanks to the brand spillover effect of several fist products of Maotai, Maotai-flavor liquor will usher in three to five years, or it will replace Luzhou-flavor liquor to set off the second rotation fragrance boom. According to market analysts, the market size of Maotai-flavor liquor is likely to exceed 200 billion yuan in the next five years.
Extended data
Here comes Maotai Hospital:
On April 13, a topic of "Maotai/KLOC-0.9 billion to run a hospital" was posted on a hot search, which triggered a hot discussion among netizens. It turns out that Kweichow Moutai Group recently announced that its Maotai Hospital (Maotai Hospital of Zunyi Medical College) will be completed and put into use in June.
The recruitment brochure given by Maotai Hospital shows that the introduction fee of 200,000 yuan and 500,000 yuan is given to master and doctor respectively, and the introduction fee of 654.38+10,000 yuan is given to those with qualification certificate and training certificate, and the annual salary is not less than 200,000 yuan.